[[[Translated article]]Implementation of Recommendations for the Management of Psoriasis During Preconception, Pregnancy, Postpartum, Breastfeeding, and Perinatal Care

Actas Dermosifiliogr. 2022 Jun 9:S0001-7310(22)00477-X. doi: 10.1016/j.ad.2022.06.003. Online ahead of print.

ABSTRACT

OBJECTIVE: To analyse the rate of implementation of the Psoriasis Group (GPS) recommendations for the management of psoriasis during preconception, pregnancy, postpartum, and breastfeeding.

METHODS: A closed, structured, anonymous survey was designed and sent in electronic format to GPS members via email. Sociodemographic and professional variables were collected, as well as others related to the proposed objectives. A descriptive analysis was performed.

RESULTS: A total of 53 surveys were analysed. We found that 96% of the participants are aware of the GPS recommendations but the level of participation in multidisciplinary care units or the provision of specific protocols in dermatology departments is very low. Many participants (70%) regularly ask about pregnancy desire, although only 46% ask men and women. Preconception counselling is offered more often to women than men (54% vs 19%). There was a great variability in the type of counselling offered. Around 90% of topical treatments are stopped during pregnancy and almost 100% of systemic therapies except for cyclosporine A. In the third trimester, most of biological therapies are postponed with the exception of certolizumab pegol. Topical treatments, phototherapy and certolizumab pegol are used by almost 100% of the participants during breastfeeding. The lack of time, support from stakeholders and robust data are the main limitations to the implementation of the GPS recommendations.

CONCLUSIONS: Although the GPS recommendations are widely known, there are still areas for improvement.

PMID:35691332 | DOI:10.1016/j.ad.2022.06.003